Product image of Linezolid Hcs (Linezolid) supplied by GNH India

Linezolid Hcs

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Hcs (Linezolid)

Linezolid, the active ingredient in Linezolid Hcs, is an oxazolidinone presented as an oral tablet for oral use. It treats infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), and is indicated for community‑acquired bacterial pneumonia.

GNH India supplies Linezolid Hcs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Hcs Bvba

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic used to treat serious Gram‑positive bacterial infections.

  • Methicillin‑resistant Staphylococcus aureus (MRSA): provides effective bacterial clearance in skin, soft‑tissue and bloodstream infections.
  • Vancomycin‑resistant Enterococcus (VRE): offers an alternative treatment option for infections resistant to standard therapy.
  • Community‑acquired bacterial pneumonia: achieves clinical cure by targeting the causative Gram‑positive pathogens.
  • Other susceptible Gram‑positive infections: resolves infections caused by bacteria that are sensitive to linezolid.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of the initiation complex required for translation. This action blocks the production of essential proteins, leading to bacteriostatic activity against susceptible Gram‑positive organisms.

Side Effects

Linezolid may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools that may be self‑limiting.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste perception.
  • Myelosuppression: mild reductions in blood cell counts.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count requiring monitoring.
  • Peripheral neuropathy: nerve damage presenting as tingling or numbness.
  • Optic neuritis: visual disturbances that may be irreversible.
  • Lactic acidosis: metabolic acidosis with elevated lactate levels.
  • Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents.

Precautions & Warnings

When prescribing Linezolid, clinicians should consider several safety measures.

  • Monitor blood counts: regular CBCs to detect myelosuppression.
  • Assess renal function: adjust therapy in patients with severe renal impairment.
  • Avoid serotonergic drugs: co‑administration can precipitate serotonin syndrome.
  • Caution in seizure history: linezolid may lower seizure threshold.
  • Evaluate hepatic status: consider liver function in prolonged therapy.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Linezolid interacts with several medication classes that may require dose adjustment or avoidance.

Major Interactions (Avoid)

  • MAO inhibitors: risk of severe hypertension and serotonin syndrome.
  • SSRIs, SNRIs, and other serotonergic agents: can precipitate serotonin syndrome.
  • Rifampin: markedly reduces linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: may increase INR and bleeding risk.
  • NSAIDs: potential for enhanced bleeding.
  • Antacids containing magnesium or aluminum: may affect absorption of linezolid.

Frequently Asked Questions

Linezolid Hcs is indicated for infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococcus (VRE), and community‑acquired bacterial pneumonia. It is used when these pathogens are identified or strongly suspected.

Linezolid binds to the 50S subunit of bacterial ribosomes, blocking the formation of the initiation complex needed for protein synthesis. This inhibition halts bacterial growth, providing a bacteriostatic effect against susceptible Gram‑positive organisms.

The dosage of Linezolid Hcs is determined by the prescribing clinician based on the specific infection, patient weight, renal and hepatic function, and local treatment guidelines. Patients should follow the exact regimen provided by their healthcare professional.

The safety of Linezolid Hcs in pregnancy and lactation has not been definitively established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order Linezolid Hcs, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Linezolid offers a purely oral option with activity against MRSA, whereas many alternatives such as vancomycin require intravenous administration. Its mechanism differs from beta‑lactams and glycopeptides, providing a valuable option when resistance or intolerance to other agents is present.

Linezolid Hcs should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the tablet’s stability and potency throughout its shelf life.

Linezolid Hcs is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with an adequate amount of water and not chewed or crushed unless specifically instructed.

Serious risks include thrombocytopenia, peripheral neuropathy, optic neuritis, lactic acidosis, and serotonin syndrome when combined with serotonergic drugs. Patients should be monitored regularly for hematologic changes and neurological symptoms, and any signs of severe adverse reactions require immediate medical attention.

Linezolid Hcs should be avoided in patients currently taking monoamine oxidase inhibitors (MAOIs) or other serotonergic agents due to the risk of serotonin syndrome. It is also contraindicated in individuals with known hypersensitivity to linezolid or any component of the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT